GeneralConnection.com ➔ Dictionary
Dictionary Search

hematologic

Synonyms

Adjective

1. haematological

2. hematological, medicine, medical specialty

Usage
Orca-T–Based Approaches Could Drive GVHD Management Shifts in Advanced Hematologic Malignancies - OncLive
From Conference to Practice: Top 5 Takeaways From EHA 2026 - CancerNetwork
Ajay Major: Underrecognized and Modifiable Challenge of Patients with Hematologic Malignancies - Oncodaily
Ian Krop MD, PhD named Section Chief of Medical Oncology and Hematology and Deputy Director for Clinical Affairs for Yale Cancer Center and Smilow Cancer Hospital | Newswise - Newswise
Tafasitamab Combo Improves Survival in DLBCL Trial - Oncology News Central
DISC-0974 Produces Meaningful Hematologic Responses in Myelofibrosis-Associated Anemia - Targeted Oncology
Four-Year Data Confirm Anifrolumab Efficacy in Lupus - MedPage Today
VIDEO: Data support further study of radiopharmaceuticals in metastatic prostate cancer - Healio
RALLY-MF: Anti-Hemojuvelin Antibody DISC-0974 Yields Hematologic Responses in Patients With Anemia and Myelofibrosis - ASCO Daily News
Nurse-Led Quality Initiative Reduces CLABSI Risk in Hematologic Cancer Care - Cure Today
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology - AJMC
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress - PR Newswire
Diagnosing Congenital Hemangiomas in Newborns With Thrombocytopenia - Hematology Advisor
Investigating blood cell images for enhanced hematologic disorder detection using multi-scale feature learning with a hybrid deep learning model - Nature
Naveen Pemmaraju: Celebrating BPDCN Breakthroughs With the Hematology Community at EHA2026 - Oncodaily
Unraveling Key Hematologic Oncology Developments at ASCO 2026 - CancerNetwork
Teclistamab Shows Promise in High-Risk Smoldering Multiple Myeloma - Oncology News Central
Interpretable multiple instance learning for hematologic diagnosis from peripheral blood smears - Nature
FDA Widens Access to Marstacimab-hncq for Hemophilia A and B - Hematology Advisor
FDA Approves Pivekimab Sunirine in Rare Hematologic Malignancy - CancerNetwork
Deucrictibant Prophylaxis May Safely Prevent Attacks in Hereditary Angioedema - Hematology Advisor
NCCN 2026 Annual Congress: Hematologic Malignancies™️ - The Cancer Letter
Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies - Nature
Register Today for Roswell Park’s Upstate New York Hematology & Hematologic Oncology Conference - Roswell Park Comprehensive Cancer Center
Solving Riddles Through Sequencing (SIRIUS): unlocking hematologic diagnoses by whole genome and transcriptome sequencing | Leukemia - Nature
Ocular toxicities of targeted therapies and immunotherapies in hematologic malignancies - Frontiers
Unveiling economic and humanistic burden of hematologic malignancies in Japan with personal health record data - Nature
Understanding the Psychoneurological Symptom Cluster in Adults With Hematologic Malignancies - Oncology Nursing News
5 Ongoing Phase 3 Trials in Hematologic Malignancies - AJMC
Deciphera Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 INTREPID Study of Sapablursen in Polycythemia Vera - Business Wire
Shifting Hematologic and Solid Tumor Units to Progressive Care Models - CancerNetwork
Optimizing Symptom Management in Hematologic Oncology: Empowering Oncology Nurses - Cancer Nursing Today
Frontline Combos Take the Spotlight: Previewing the Top Hematologic Oncology Presentations at ASCO 2026 - OncLive
Orca-T May Make Transplants Safer, More Effective in Hematologic Cancers - CancerNetwork
Pathophysiology, evaluation, and management of malnutrition in hematologic malignancies: a comprehensive review - Frontiers
Hematologic Emergencies: Recognition and Initial Management - American Academy of Family Physicians | AAFP
Hematologic and coagulation responses to Johnson & Johnson COVID-19 vaccination in the Amhara region, Ethiopia - Nature
Phase 1 Mosunetuzumab Data Inspires Phase 3 MorningLyte Study - CancerNetwork
Polls Reveal Picks for Top Hematologic Oncology Abstracts at ASCO 2026 - OncLive
Accelerated Approval Granted to Beqalzi for Mantle Cell Lymphoma - Clinical Oncology News
Shifting Towards Cell Therapy Optimization Across Hematologic Malignancies - CancerNetwork
Dr Smith on Translating CAR T-Cell Therapies From Hematologic to Solid Malignancies - OncLive
Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk - NEJM
Society of Hematologic Oncology opens registration for case-based MDS/AML program ahead of SOHO 2026 - PR Newswire
ASH 2023: Advancing Potential Breakthroughs for Patients with Hematologic Disorders - Pfizer
Managing Hematologic Toxicities with ADCs: Neutropenia, Growth Factor Support, and Thrombocytopenia in Breast and Lung Cancer - OncLive
Orca-T May Be “Important Step Forward” in Hematologic Malignancy Care - CancerNetwork
Tafasitamab/Lenalidomide Plus R-CHOP Improves PFS in High-Risk DLBCL - Clinical Oncology News
ChatGPT Found Lacking for Hematologic Cancers - Hematology Advisor
Ian Krop Appointed Section Chief of Medical Oncology and Hematology - Yale Cancer Center - Oncodaily
Reducing the Barriers to Receiving CAR T-Cell Therapy for Patients With Hematologic Malignancies - The ASCO Post
Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignancies - Nature
Orca-T Shows “Reassuring” Outcomes Across Hematologic Malignancies - CancerNetwork
FDA Grants RMAT Designation to Orca-Q for High-Risk Hematologic Malignancies - OncLive
The Evolving Treatment Landscape: Nurse Practitioners Reflect on Progress in Hematologic Oncology at ASH 2025 - Cancer Nursing Today
Insights Across Hematologic Oncology at Columbia University - CancerNetwork
Optimizing Transplantation Outcomes Across Hematologic Oncology Populations - CancerNetwork
Talquetamab Combinations Extend Survival in RRMM: EHA 2026 - EMJ
Orca-T With Myeloablative Conditioning Yields Increased Survival, Lowered NRM in Hematologic Malignancies - OncLive
ASH 2025: The Top 10 Takeaways for Hematologic Oncology Care - CancerNetwork
Metabolic reprogramming in tumor-associated cells of hematologic malignancies: mechanisms, crosstalk networks, and therapeutic implications in the tumor microenvironment - Frontiers
Orca-T Diversifies Well-Tolerated Post-Transplant Treatment Options for Hematologic Malignancies - OncLive
Hematology Launches Virtual Iron Deficiency Clinic - School of Medicine | University of Utah
Translational potential of γδ T cells in hematologic diseases: from immunobiology to therapeutic innovation - Frontiers
FDA Extends Review Period for Orca-T in Hematologic Malignancies - CancerNetwork
ASTRO Radiopharmaceutical Symposium 2026: Hematologic Toxicity Outcomes of Lu-PSMA-617 in Patients Previously Treated with EBRT for Oligometastatic Disease - UroToday
Could Hematologic Markers Be Prognostic for Survival in RCC? - CancerNetwork
Lea Haines: We Had a Great European Hematology Association Congress in Stockholm This Year - Oncodaily
Incorporating mRNA therapeutics into biological treatments of hematologic malignancies - Frontiers
Sepsis detection in hematologic and solid tumor malignancies using quantitative inflammatory biomarker differences in a prospective single center study - Nature
Advancing Hematology Research at EHA 2026 – Bristol Myers Squibb - Oncodaily
Prof. Claire Harrison Honored with 2026 EHA Lifetime Achievement Award - Oncodaily
Hematologic Malignancies Market Size is Projected to Reach - GlobeNewswire
Liquid Biopsy in Hematologic Malignancies: Advances, Challenges, and Future Directions - Wiley Online Library
SOHO 2025 Keynote Speakers Highlight Progress in Hematologic Oncology - The ASCO Post
Analysis Shows Consistent Manufacturing and Distribution of Orca-T in Hematologic Malignancies - OncLive
Yelena Janjigian: Honored to Receive the 2026 Hematology and Medical Oncology Fellowship Service Award - Oncodaily
FDA Grants Priority Review to Orca-T for Hematologic Malignancies - OncLive
Traditional clinical risk factors outperform disease activity and hematologic indices for FRAX hip fracture risk in rheumatoid arthritis - Frontiers
FDA Extends Review of BLA for Orca-T in Hematologic Malignancies - OncLive
Multi criterion decision making analysis of hematologic cancer drugs via topological indices and physicochemical properties - Nature
How ctDNA is redefining MRD monitoring in hematologic cancers - Fierce Biotech
Orca-T With Reduced-Intensity Conditioning Yields Robust Efficacy in Hematologic Malignancies - OncLive
ANCO’s Hematologic Malignancies Update 2026 - Oncodaily
In Vivo CD19/CD20 CAR T-Cell Therapy Is Safe, Yields 100% ORR at Phase 1, Dose Level 2 in R/R Non-Hodgkin Lymphomas - OncLive
Top Early Phase Hematologic Oncology Trials to Watch at EHA 2026 - Oncodaily
Myeloablative Orca-Q Yields High Engraftment Rates in High-Risk Hematologic Malignancies With Haploidentical Donors - OncLive
Study Shows ChatGPT Struggles With Patient-Specific Queries, Novel Therapies in Hematologic Malignancies - OncLive
Nutrition Support Could Influence Outcomes in Caring for Patients With Hematologic Malignancies - ashpublications.org
Palliative care for patients with hematologic malignancies — challenges and perspectives - Via Medica Journals
Experts to Discuss Co-Managing Complex Hematologic Issues During Pregnancy, Delivery - ashpublications.org
Sphingolipid metabolism and hematologic disorders: current understanding and future directions - Frontiers
New Co-Chief Fellows Named at Texas Children’s Cancer and Hematology Center - Texas Children’s
HearteXplain: explainable prediction of acute heart failure and identification of hematologic biomarkers using EBMs and Morris sensitivity analysis - Nature
Risks of cataract surgery in solid and hematologic cancer survivors - Nature
How Investors May Respond To AbbVie (ABBV) Leaning On Hematology And Migraine Portfolios Beyond Legacy Blockbusters - simplywall.st
For clonal hematopoiesis, epigenetics can be in driver’s seat - BioWorld News
Lyell Immunopharma Presents Updated Safety Data and Translational Insights for Rondecabtagene Autoleucel (Ronde-Cel) in Patients with Large B-Cell Lymphoma at European Hematology Association 2026 Congress - GlobeNewswire
Ziftomenib + Intensive Chemotherapy in ND NPM1-Mutated and KMT2A-Rearranged AML: KOMET-007 Results - Oncodaily
BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026 - BioSpace
Foreign Language Equivalents
Foreign Language Equivalents of 'hematologic'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
hematloogic,   heatologic,   hemaologic,   hematoloogic,   hematologiv,   hemarologic,   hematollogic,   hematilogic,   heamtologic,   hemayologic,   hemmatologic,   hematologoc,   hematokogic,   hematoologic,   hemato;ogic,   jematologic,   hematologuc,   hmeatologic,   hmatologic,   hwmatologic,   hematologicc,   hematplogic,   hemaatologic,   he,atologic,   hematolpgic,   hematologci,   hrmatologic,   hemaotlogic,   hemattologic,   hemtaologic,   hematologgic,   hemstologic,   hematlogic,   hematolohic,   ehmatologic,   gematologic,   heematologic,   hematolofic,   ematologic,   henatologic,   hematoloigc,   hematologix,   hematoloic,   hematolgic,   hhematologic,   hematoligic,   hematologiic,   hematologi,   hematoolgic,   hematologc,   hematolgoic,   hematoogic,   hemtologic
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z